BFS
RCKT icon

Bare Financial Services’s Rocket Pharmaceuticals RCKT Stock Holding History

Bare Financial Services’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16K Buy
+340
New +$1.13K ﹤0.01% 1319

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Bare Financial Services's RCKT Position: Q2 2026 in Review

Bare Financial Services opened a new position in Rocket Pharmaceuticals (RCKT) in Q2 2026: 340 shares worth $1.16K. The stake represents ﹤0.01% of the portfolio and ranks #1319 among its holdings.

180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Bare Financial Services held 340 shares of Rocket Pharmaceuticals worth $1.16K as of Q2 2026.
  • Rocket Pharmaceuticals was a new Bare Financial Services position in Q2 2026.
  • Rocket Pharmaceuticals made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #1319 holding.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.